APA

Bouclier C., Simon M., Laconde G., Pellerano M., Diot S., Lantuejoul S., Busser B., Vanwonterghem L., Vollaire J., Josserand V., Legrand B., Coll J., Amblard M., Hurbin A. & Morris M. C. (20210414). Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. : Theranostics.

Chicago

Bouclier Celine, Simon Matthieu, Laconde Guillaume, Pellerano Morgan, Diot Sebastien, Lantuejoul Sylvie, Busser Benoit, Vanwonterghem Laetitia, Vollaire Julien, Josserand Véronique, Legrand Baptiste, Coll Jean-Luc, Amblard Muriel, Hurbin Amandine and Morris May C. 20210414. Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. : Theranostics.

Harvard

Bouclier C., Simon M., Laconde G., Pellerano M., Diot S., Lantuejoul S., Busser B., Vanwonterghem L., Vollaire J., Josserand V., Legrand B., Coll J., Amblard M., Hurbin A. and Morris M. C. (20210414). Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. : Theranostics.

MLA

Bouclier Celine, Simon Matthieu, Laconde Guillaume, Pellerano Morgan, Diot Sebastien, Lantuejoul Sylvie, Busser Benoit, Vanwonterghem Laetitia, Vollaire Julien, Josserand Véronique, Legrand Baptiste, Coll Jean-Luc, Amblard Muriel, Hurbin Amandine and Morris May C. Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth. : Theranostics. 20210414.